| (Values in U.S. Thousands) | Jun, 2019 | Mar, 2019 | Dec, 2018 | Sep, 2018 | Jun, 2018 |
| Sales | 4,580 | 3,040 | 4,670 | 2,960 | 1,670 |
| Sales Growth | +50.66% | -34.90% | +57.77% | +77.25% | +12.08% |
| Net Income | -10,660 | -9,680 | -7,430 | -7,600 | -9,910 |
| Net Income Growth | -10.12% | -30.28% | +2.24% | +23.31% | +1.39% |
Corindus Vascular Robotics Inc (CVRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Corindus Vascular Robotics, Inc. is involved in designing, manufacturing and selling precision vascular robotic-assisted systems for interventional vascular procedures. The Company's product includes CorPath 200 system a vascular robotic system which provide stent placement in percutaneous coronary intervention procedures. Corindus Vascular Robotics, Inc. is based in Waltham, Massachusetts.
Fiscal Year End Date: 12/31